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1. Introduction
Affinity  chromatography  which  is  known  as  a  liquid  chromatographic  technique  for
separation and analysis of biomolecules based on their biological functions or individual
structures has become increasingly important and useful separation method in pharmaceut‐
ical science, biochemistry, biotechnology and environmental science in recent years [1]. This
technique  is  especially  known  as  the  most  specific  and  effective  technique  for  protein
purification  [2].  Separation  of  the  biomolecules  is  based  on  highly  specific  biological
interactions  between  two  molecules,  such  as  enzyme  and  substrate.  These  interactions,
which are typically reversible, are used for purification by placing one of the interacting
molecules, referred to as affinity ligand, onto a solid matrix to create a stationary phase
while the target molecule is in the mobile phase [3]. Any component can be used as a ligand
to purify its respective binding partner. Some typical biological interactions, frequently used
in affinity chromatography, can be given as;
• Enzyme. ↔  substrate analogue, inhibitor, cofactor.
• Antibody ↔ . antigen, virus, cell.
• Lectin ↔ . polysaccharide, glycoprotein, cell surface receptor, cell.
• Nucleic acid ↔ . complementary base sequence, histones, nucleic acid polymerase, nucleic
acid binding protein.
• Hormone, vitamin ↔ . receptor, carrier protein.
• Glutathione ↔ . glutathione-S-transferase or GST fusion proteins.
© 2013 Acikara et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
• Metal ions ↔ . Poly (His) fusion proteins, native proteins with histidine, cysteine and/or
tryptophan residues on their surface [4-5].
In case a ligand is immobilized on a polymeric carrier, usually by covalent coupling, and
filled in a column, it is possible to separate the substances which have affinity to the ligand
and  the  other  substances.  As  the  solution  containing  the  biologically  active  substance
applied to the column, the compounds which have no affinity to the insoluble ligand will
pass through the column and the biologically active compound will  be captured on the
column, in favorable conditions. The sorbed compounds can then easily be dissociated by
changing the external conditions, such as ionic strength, pH, solvent, temperature etc. or
alternatively  by using dissociating agents  [6-7].  As  a  result,  it  is  possible  to  isolate  and
purify the analyte or  make quantitative analysis  with a suitable,  immobilized ligand by
means of molecular recognition [1-2].
Macromolecules such as proteins, polysaccharides, nucleic acids differ only in their physico-
chemical properties within the individual groups and their isolation on the basis of these
differences is  therefore difficult  and time consuming.  Considerable decreases may occur
during their isolation procedure due to denaturation, cleavage, enzymatic hydrolysis, etc.
The ability to bind other molecules reversibly is one of the most important properties of
these molecules. The formation of specific and reversible complexes of biological macromo‐
lecules  can  serve  as  basis  of  their  separation,  purification  and  analysis  by  the  affinity
chromatography [6].
Affinity chromatography is one of the oldest forms of liquid chromatography method [8]. The
first use of the idea of affinity chromatography may be considered as the isolation of α-amylase
by using an insoluble substrate, starch, in 1910 by Starkenstein [6,9]. Similar studies with starch
and amylase were carried out in the 1920s through 1940s by other investigators. In another
study polygalacturonase was used as a support and ligand for the adsorption of alginic acid,
the purification of pepsin through the use of edestin, a crystalline protein and the isolation of
porcine elastase with powdered elastin were also performed. Afterwards Willstatter et al.
enriched lipase by selective adsorption onto powdered stearic aicd [10]. The majority of the
previous studies related purification of the enzymes. However the selective purification of
antibodies with biological ligands was also being conducted. In 1920, it was reported that
antibodies can recognize and bind substances with a specific structure, "antigens" [8]. This
principle is firstly used in order to isolate rabbit anti-bovine serum albumin antibodies on a
specific immunoadsorbent column consisting bovine serum albumin coupled to diazotized p-
aminobenzyl-cellulose [10]. According to this approach, antibodies were isolated using urease
and exhibited that these antibodies were proteins [8].
Separation procedure in affinity chromatography can be simply illustrated as shown in Figure
1. A sample containing the compound of interest is applied to the affinity column in the
presence of mobile phase which was prepared in suitable pH, ionic strength and solvent
composition for solute-ligand binding. This solvent which is referred as the application buffer
presents the weak mobile phase of an affinity chromatography. While the sample is passing
through the column compounds which are complementary to the affinity ligand will bind.
However other solutes in the sample will tend to be washed off or eluted from the column as
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nonretained compounds. After all nonretained components are washed off the column,
binding solute or together with ligand as solute-ligand complex are eluted by applying a
solvent. This solvent which is referred as elution buffer represents the strong mobile phase for
the column. Later all the interested solutes are eluted from the column, then application buffer
is applied and the column is allowed to regenerate prior to the next sample application [4,8].
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Sample is applied under optimum conditions that favor 
specific binding of the target molecule(s) to complementary 
binding molecules (the ligand). Desired molecules bind 
specifically, but reversibly, to the ligand and unbound 
material is washed through the column.
Affinity medium is equilibrated with binding buffer 
Target protein is recovered by changing conditions to favor 
elution of the bound molecules. Elution is performed 
specifically using a competitive ligand, or non‐specifically, by 
changing the pH, ionic strength or polarity. Target protein is 
collected in a purified, concentrated form.
Affinity medium is re‐equilibrated with binding buffer  
Figure 1. Separation procedure in affinity chromatography
The conditions in which the sample is applied to the column are chosen considering the
conditions which the interaction between analyte and ligand is strong, mostly resembling the
natural conditions of the analyte and ligand. The content apart from the analyte passes through
the column without or with weak binding to the ligand while the analyte is retarded. After the
analyte is obtained generally by using an elution buffer, the column is regenerated by washing
with the application buffer in order to prepare the column for the next injection [1]. In the
Figure 2, a typical scheme of an affinity chromatography application is shown.
As it is defined above; this technique is based on the interactions between specific bioactive
substances, so the ligands are supposed to be originally biological substances, nevertheless
columns with nonbiological ligands are also available and the same term “affinity chroma‐
tography” is used for the techniques performed by using these ligands. In order to distinguish
the techniques according to the origin of the ligand, affinity chromatography with biological
ligands may be termed as “bioaffinity chromatography” or “biospesific adsorbtion” [1]. The
wide application potential of affinity chromatography leaded to the development of derived
techniques some of which are listed below [7].
• Immunoaffinity chromatography
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• High performance affinity chromatography
• Affinity density perturbation
• Library-derived affinity ligands
• Lectin affinity chromatography
• Affinity partitioning
• Dye-ligand affinity chromatography
• Affinity electrophoresis
• Affinity capillay electrophoresis
• Centrifuged affinity chromatography
• Filter affinity transfer chromatography
• Affinity precipitation
Figure 2. An example of a typical scheme of an affinity chromatography application [1].
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• Avidin-biotin immobilized system
• Affinity tails chromatography
• Affinity repulsion chromatography
• Perfusion affinity chromatography
• Theophilic chromatography
• Weak affinity chromatography
• Receptor affinity chromatography
• Membrane-based affinity chromatography
• Molecular imprinting affinity
• Metal-chelate affinity chromatography
• Covalent affinity chromatography
• Hydrophobic chromatography
Affinity chromatography utilizes specific and irreversible biological interactions between a
ligand covalently coupled to a support material and its complementary target. The solid
support and ligand covalently attached on it, selectively adsorbs the complementary substance
from the sample. The unbound part of the sample is removed and the purified substance can
easily be recovered [11]. Selectivity of the ligand, recovery process, throughput, reproducibil‐
ity, stability and economical criteria are some of the factors that influence the success of affinity
chromatography process [9]. Successful affinity purification requires a certain degree of
knowledge and understanding of the nature of interactions between the target molecule and
the ligand to help determine the selection of an appropriate affinity ligand and purification
procedure [3]. Therefore prior to start the process, materials and specifications listed below
need to be selected [11]:
• Support material
• Activation method
• Ligand
• Immobilization method
• Conditions for adsorption and desorption
1.1. Support material
For successful separation in affinity chromatography, the important parameter is that solute
of interest should be bound firmly and specifically while leaving all other molecules. This
requires that the support within the column contain an affinity ligand that is capable of
forming  a  suitably  strong  complex  with  the  solute  of  interest  [8].  The  other  important
property is that the, support material must be biologically and chemically inert to avoid
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the unspecific bindings [8,11] which requires that the support has a chemical character that
is  very similar  to  that  of  the  medium in which it  is  operating.  Since  almost  all  affinity
separations  occur  in  aqueous  solutions,  the  support  should  thus  be  as  hydrophilic  as
possible. As a rule, the mobile phase used in affinity separations has a low ionic strength.
The support should therefore contain as few charges as possible to prevent ionic interac‐
tions.  Many  supports  are  available  which  have  desired  properties  or  they  gain  such
characteristics  by  hydrophilic  coating [8].  Generally  solid  materials  are  used as  support
material though some soluble macromolecular materials are sometimes preferred for two-
phase  aqueous  affinity  partition  processes.  Uniformity  in  particle  size  and  ease  of  the
activation process are also required for support material that is used in affinity chromatog‐
raphy applications [11]. For the affinity chromatography at low pressure, nonrigid gels with
large particle size are generally used as support materials while materials with small, rigid
particles or synthetic polymers which are stable under high pressure and flow rates are
used in high performance affinity applications [8,12].
There are many commercially available support materials for affinity chromatography can be
divided into three groups as; natural (agarose, dextrose, cellulose); synthetic (acrylamide,
polystyrene, polymethylacrylate) and inorganic (silica, glass) materials [7,13]. The most
popular support material is agarose [13]. Agarose was used in the first modern application of
affinity chromatography and still the most commonly preferred one [8]. Agarose consists of
alternatively linked 1,3 bound β-D- galactopyranose and 1,4 bound 3,6-anhydro-α-L-galacto‐
pyranose, as shown in Figure 3 [8,14]. Agarose gels are stable to eluants with high concentra‐
tions of salt, urea, guanidine hydrochloride, detergents or water-miscible organic solvents but
its stability is less beyond pH 4-9. To increase the thermal and chemical stability, cross-linked
agarose is prepared. Cross-linked agarose is commercially available (Sepharose) and it can be
used with many solvents, over pH 3-14 and at high temperatures up to 70°C [11]. However,
strong acids, oxidizers as well as some rare enzymes may be harmful to agarose due to their
damaging effects. On the other hand mild acid hydrolysis increases the quantity of sterically
available galactose residues and turns agarose into an excellent sorbent for galactose binding
proteins [14]. Due to its large beads and macroporous, accessible pore structures, agarose is
well designed for use with large molecules. High capacity, presence of functional groups, good
chemical stability especially at high pH, low non-spesific binding and good reproducibility
are the advantage of agarose. Some properties of agarose such as solubility in hot water and
non-aqueous solutions, sensitivity to microbial degredation and lack of rigidity restrict the
usage under low or medium pressure [15]. Furthermore agarose must not be frozen or air
dried. It is sold under several trade names, including Sepharose Fast Flow or Affi-Gel.
Cellulose is another example of polysaccharides which is used as support in affinity chroma‐
tography. Cellulose has a historical significance. Phospo- and DNA-cellulose are used
especially for DNA related separations [14]. Antibody and enzyme purifications have also been
carried out. However its fibrous and non-uniform character limits its use since cellulose detains
macromolecules [11].
Dextran which is a linear α-1,6-linked glucose polymer produced by Leuconostoc mesenter‐
oides is also used in affinity chromatography. Sephadex (cross-linked by glyceryl bridges) and
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Sephacryl (allyldextran cross-linked by N,N’-methylenebisacrylamide) are the two types of
dextran gel used in separation. Sephadex is mainly used as a glucose polymer and employed
for purification of many molecules such as lectins from Helix pomatia and Vicia faba, exoamylase
from Pseudomonas stutzeri [14].
Polystyrene (Figure 4), which is a polymeric support is also unsuitable in its original form for
affinity separations due to the highly hydrophobic character. Native polystyrene, which is
often used as a reversed-phase material, must be first rendered hydrophilic by one of various
surface-coating techniques before used in other chromatographic methods [8].
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Figure 4. (a) Structure of polystyrene divinilybenzene (b) SEM image of polystyrene beads(x500) [17]
Polymeric supports based on polyacrylamide are synthesized by copolymerization of acryla‐
mide and a cross-linking reagent and can be used directly in affinity chromatography due to
its more hydrophilic properties than polystyrene supports. Polyacrylamide gels are either soft
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Figure 3. (a). Structure of agarose (b). SEM image of agarose [16]
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or have small pores. However this gel is resistant against enzymatic attacks and does not absorb
biomolecules, thus it is used widely despite its mechanic disadvantages [8,14].
Inorganic materials such as porous glass and silica are used when the extreme rigidity of the
support material is needed [14]. Silica is especially used in the high-performance liquid affinity
chromatography (HPLAC) or high-performance affinity chromatography (HPAC). Silica-
based materials (Figure 5) are basically hydrophilic and they are suitable for affinity chroma‐
tography after they are modified at their surface. The native surface of silica is primarily
covered with silanol groups which are weak acids and give strong negative charge to silica’s
surface at neutral pH. Irreversible adsorption of solutes (protein) can occur due to these charges
and in combination with other binding forces. However, several methods can be used to render
this surface inert toward such solutes, including polymer coating techniques and reactions
between silica and alcohols or trialkoxysilanes [8]. They are also soluble at pH above 8 thus
pH is an important parameter that limits the usage of silica [14].
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Figure 5. (a) Structure of silica (b) SEM picture of typical silicagel [18]
A support material should be inert toward solutes. On the other hand easy coupling with
ligand is also desired. Support materials are rich in hydroxyl groups, therefore attachment of
ligands have been focused mainly on using these regions as anchoring points. Ideal affinity
support should allow unhindered access of a solute to the immobilized ligand. For a macro‐
molecular solute, this requires a support that has large pores. Renkin equation can explain
these pore sizes to be that allows one to estimate the effective diffusion coefficient (Deff) of a
solute in a porous material.
Deff  =D  KDεp 1−2.10(Rs / Rp) + 2.09(Rs / Rp)3−0.095(Rs / Rp)5 / t
In this equation, Rs/Rp is the ratio of the solute's radius (Rs) to the pore radius (Rp), εp is the
particle porosity, τ is the tortuosity factor, KD is the distribution coefficient for the solute, and
D is the diffusion coefficient for the solute in free solution. By inserting different values for the
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ratio Rs/Rp, one finds that the pore diameter should be at least five times the diameter of the
solute to avoid severely restricted rates of diffusion.
For a protein in normal size (i.e., a diameter around 60 Å), a ratio of five for Rp/Rs means that
the support pores should be in the range of 300 Å. Several common supports are available with
such pore sizes. Support materials with very large pores give essentially unhindered diffusion
for most solutes, but they also have a smaller surface area per milliliter of bed volume than
supports with smaller pores. This reduced surface area leads to a diminished binding capacity.
As a rule, a pore size of 300 to 700 Å is usually a good compromise in most situations encoun‐
tered in affinity chromatography, since this gives fairly unrestricted diffusion for most
biomolecules while also providing a relatively large surface area for retention [8].
Particle diameters of the affinity supports are available in a wide variety. These range from
HPLC-type materials with diameters of 10 µm or less to large particles for preparative work
that have diameters of 400 µm. The purpose of the separation, mechanical properties of the
support and the characteristics of the sample are important factors on the selection of particle
size of the support. From a theoretical viewpoint, it is always advantageous to have a small
particle size, since this will promote fast mass transfer of a solute between the outer flow stream
and interior of a support particle. Sample molecules are transported down through the column
by the flow of the mobile phase in the spaces between the support particles. To reach the affinity
ligands, these molecules must diffuse through the stagnant mobile-phase layer surrounding
the particles (i.e., the film model) and proceed to the inside pore network (Figure 6). It is where
the sample molecules will finally bind to the affinity ligand. When the retained molecules are
eluted, the same steps occur but in a reversed order. Smaller support particles mean shorter
diffusion distances, since they have shorter pores and a thinner stagnant mobile phase layer
around and in the support. This results in shorter times needed for diffusion.
Figure 6. Transport processes that occur in a chromatographic column.
In preparative affinity chromatography, relatively large support particles are often used,
making intraparticle diffusion the main factor limiting efficiency. In this case, diminishing the
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particle size will increase the rate of movement of solutes between the support and surround‐
ing flow stream, giving an improved column performance. It is this effect that was the original
driving force behind the use of smaller supports in affinity columns, thus giving rise to the
technique of HPLAC. Under such conditions, a decrease in particle size by a factor of five can
make it possible to increase the flow rate by up to 25-fold and still retain good chromatographic
performance. This results in a dramatic improvement in the productivity of the system.
However, a point is eventually reached when a decrease in particle diameter no longer gives
a proportional improvement in an affinity column's performance. This has been observed in
many analytical-scale systems that use HPLC-type supports with particle sizes less than 10
µm in diameter. Under these conditions, diffusion in the particle is now relatively fast, and it
is the adsorption/desorption of sample molecules to and from the affinity ligand that becomes
the limiting factor in speed and efficiency. Although better efficiency is always obtained with
small support particles, using a small particle size tengenders some difficulties. One problem
is the much higher flow resistance of these smaller particles. This increased flow resistance
may lead to bed collapse when using soft gels such as agarose. And, although supports like
silica can tolerate the higher pressures, that results, these will require the use of more expensive
pumps to work at such pressure, as is generally done in HPLC. Another route that could be
taken with small affinity supports is to use a short and wide column instead of a long and
narrow one. The advantages of this are that the shorter, wider column can be run at higher
flow rates without creating high-pressure drops. Another drawback with small particle sizes,
especially in preparative work, is the increased danger of fouling that exists when particulate
contaminants are in the feed stream or sample. This occurs because the interstitial spaces in a
bed of small particles can be too narrow for such agents to pass through. Such fouling will
increase the flow resistance and may lead to bed collapse if the support material does not have
sufficient mechanical strength.
As a result of these various requirements, the particle size to pick when designing a new affinity
adsorbent will be a compromise between the desired chromatographic performances, prop‐
erties of the feed stream, and the mechanical strength of the support. Some common selections
made in specific cases will be described in the next few sections.
Porous supports like agarose, polymethacrylate, or silica beads are generally used in current
applications of affinity chromatography. However, in the past several years other types of
supports have also become available commercially. Many of these newer materials have
properties that give them superior performance in certain applications. Materials that fall in
this category include; nonporous supports, membranes, flow-through beads, continuous beds
and expanded-bed particles.
Nonporous beads with diameters of 1 to 3 µm can be an optimum choice for fast analytical or
micropreparative separations, since the limiting factor of pore diffusion is virtually eliminated
in these materials. Such beads may also be the best choice for fundamental or quantitative
studies of affinity interactions, since the binding and dissociation behavior observed in these
materials should be more directly linked with the interactions occurring between solutes and
the affinity ligand. However, there is a substantial loss of surface area and binding capacity.
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Membranes have been used for affinity chromatography in various formats, such as stacked
sheets, in rolled geometries, or as hollow fibers. Materials that are commonly used for these
membranes are cellulose, polysulfone, and polyamide. Because of their lack of diffusion pores,
the surface area in these materials is as low as it is in nonporous beads. However, the flat
geometry and shallow bed depth of membranes keep the pressure drop across them to a
minimum degree. This means that high flow rates can be used, which makes these membranes
especially well-suited for capturing proteins from dilute feed streams.
As stated earlier, porous supports with a larger diameter facilitate low column backpressures
and allow easy passage of contaminants through the column. But it is also necessary to keep
the diameter of these supports as small as possible to diminish diffusion distances and thereby
improve their chromatographic performance. One solution of these contradictory require‐
ments is to use particles that allow the flow of mobile phase directly through some of the pores.
This is done in materials known as perfusion media or through-pore particles. Flow-through
particles were initially developed in the early 1990s for ion-exchange chromatography and
were later adapted for use in affinity chromatography.
Flow-through particles have a bimodal pore configuration, in which both small diffusion pores
and large flow-through pores are present. Substances applied to a bed of this support are
transported by mobile phase flow to the interior of each particle, leaving only short distances
to be covered by diffusion to the support's surface (Figure 7). This combination leads to a
dramatic improvement in performance compared with standard porous particles of the same
size. This improvement is most pronounced in situations where slow diffusion is a limiting
factor, such as in the chromatography of large molecules (e.g., proteins) at high flow rates.
Figure 7. Comparison of a particle with normal porosity versus a particle that contains flow-through pores. The nor‐
mal particle has long diffusion distances, whereas the flow-through particle has short diffusion distances.
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Another format developed in 1990s was the continuous bed or monolithic support. Continuous
bed supports consist of a single piece of material intersected by pores large enough to support
chromatographic flow through the bed. Continuous beds have been developed using many
well-known chromatographic materials, such as polyacrylamide, silica, polystyrene/polyme‐
thacrylates, cellulose, and agarose. Most of these continuous beds have two types of pores:
large flow-carrying pores and smaller diffusion pores.
The preparation of a continuous bed is usually straightforward. These beds can often be
prepared directly in a chromatographic column, thereby avoiding the time-consuming steps
of size classification and column packing that are normally needed with particle-based
supports. Reports using continuous beds in affinity chromatography have shown that the
efficiency of these materials is as good as that for particle-based supports.
In order to avoid column clogging, various pretreatment methods like filtration and centrifu‐
gation are often necessary to remove particulate matter from samples. To cut down on the need
for such methods, a new class of adsorbents has recently been developed to handle viscous
and particle-containing feed streams. These materials are known as expanded-bed adsorbents. In
expanded-bed chromatography the direction of mobile phase flow is upward through the
column and is fast enough to fluidize the support particles in the column. This causes the
column bed to expand. This expansion makes the interstitial spaces in the column bed larger
so that solid contaminants like cells and cell debris can pass through, thereby avoiding column
clogging.
Another new type of expanded-bed adsorbent uses a thin layer of active material (i.e.,
derivatized agarose) that surrounds a heavy core. These adsorbents have small diffusion
distances for biomolecules along with a higher density than other expanded-bed particles. The
advantage of this combination is that it allows better chromatographic efficiencies to be
obtained at higher flow rates [8].
1.2. Ligand
Ligands are the molecules that bind reversibly to a specific molecule or group of molecules,
enabling purification by affinity chromatography [4]. These molecules which play a major role
in the specificity and stability of the system are essential for affinity chromatography [13]. The
selected ligand must be capable of selectively and reversibly binding to the substance to be
isolated and have some groups which are available for modifications in order to be attached
to the support material. It is very important to ensure that the modifications do not reduce the
specific binding affinity of the ligands. There are general ligands such as dyes, amino acids,
Protein A and G, lectin, coenzyme, methal chelates as well as specific ligands such as enzymes
and substrates, antibodies and antigens [19].
Affinity ligands are classified as synthetic and biological. Biological ligands are obtained from
natural sources such as RNA and DNA fragments, nucleotides, coenzymes, vitamins, lectins,
antibodies, binding or receptor proteins, or in vitro from biological and genetic packages,
employing display techniques including oligonucleotides, peptides, protein domains and
proteins. Synthetic affinity ligands are generated either by de novo synthesis or modification
Column Chromatography70
of existing molecular structures (triaznyl nucleotide-mimetics, purine and pirimidine deriva‐
tives, non-natural peptides, triazinyl dyes, other triazine-based ligands, oligosaccharide and
boronic acid analogues). These can be generated by rational design or selected from ligand
libraries. Synthetic ligands are generated using three methods;
• The rational method features the functional approach and structural template approach.
• The combinatorial method relies on the selection of ligands from a library of synthetic
ligands synthesized randomly.
• The combined method employs both methods the ligand is selected from an intentionally
prepared library based on a rationally designed ligand.
Many parameters have to be taken into account in order to select appropriate ligand. Table 1
exhibits the advantages and disadvantages of synthetic and biological ligands. Selectivity and
affinity are the main advantages of biological ligands. Such ligands can be generated by in
vitro evolution approaches and selecting from large combinatorial ligand libraries based on
biological/genetic packages. Protein ligands display special advantages for example; higher
affinities, higher proteolytic stability, preservation of their biological activity when produced
by fusion to a different protein or domain. However these ligands can be expensive and
unstable to the sterilization and cleanin conditions used in manufacturing process of biologics
because of their biological origin, chemical nature and production methods. There is high
contamination risk of the end-product with potentially dangerous leaches, in addition to
possible contaminants originated from the biological source [20].
Synthetic ligands Biological ligands
Capacity High Low to medium
Cost Low to medium Medium to high
Selectivity Medium to high Very high
Stability High Low to medium
Toxicity Medium Low
Table 1. Comparison of biological and synthetic ligands [20]
Despite the advantages of the affinity chromatography technique, its use is limited due to
high  cost  of  affinity  ligands  and  their  biological  and  chemical  instability.  The  develop‐
ment of methods for production of stable synthetic ligands has enabled “utilization of these
materials in large scale. For the design of synthetic ligands, information about structure of
the target protein and a potential binding site are required, thus a structure-based design
can be achieved, in case correct prediction of the ligand’s comformation and the binding
affinity of the designed ligand. Function-based design can be applied when the structure
of  the  target  is  not  known  [9].  Substantially,  selection  and  design  of  ligands  may  be
performed by using a template which is a part of a natural protein-ligand couple, model‐
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ling a molecule which complements the binding sites of the target or directly resembling
the natural interactions [2].
High selectivity of the biological ligands is a benefit; however these ligands have some
handicaps, such as their low binding capacity, cost-efficacy issues, some problems in scale-up
and purification process. Hence, synthetic ligands may offer a solution for these issues and
enable to provide selectivity, efficacy and inexpensiveness in a body. Biomimetic textile dyes
which are developed in 1970s are the most known synthetic ligands. The use of these dyes in
biopharmaceutical field is limited due to some issues such as selectivity, purity and toxicity.
These complications have led to new researches and developments about biomimetic dyes and
new ligand design techniques [2].
The selection of the ligand may be done according to the specific binding site of a target, but
this manner of selection may fail owing to the fact that immobilization process may change
binding affinity. It is known that the affinity of the target to the ligand is dependent on the
features of the target as well as support material, activation and coupling chemistry. Some
other techniques other than using free ligand solution in order to predict the conditions of
three-dimensional matrix. On the purpose of ligand selection, a great number of alternatives
may be tested for binding the target or work with more accurate options by employing ligand
design techniques. Therefore the idea to combine chemistry with computational tools has
accelerated the developments on this field [2]. Along the development of affinity chromatog‐
raphy techniques, different laboratories are established with the purpose of collection of
several ligands for affinity chromatography [9].
Protein-structure-based design of the ligands depends on the correct prediction of the structure
of the target protein and the binding site. Apart from this, protein-function-based design is
applicable in case the conformation of the target protein is not known. This method is based
on the integration of some known properties of the ligand such as an essential molecular
structure, a functional group or a derivative of some parts of the structure [9]. The design of a
ligand requires several steps to fulfil [2]:
1. Determination of the binding site or possible biological interactions to use as a template
for the modelling,
2. Initial design of the ligand using this template,
3. Preparation of a ligand library and chromatographic evaluation,
4. Selection of the ligand of interest,
5. Optimisation and chromatographic evaluotion of the adsorbent following the immobili‐
zation.
Beyond these design methods, some combinatorial approaches have been developed on the
purpose of ligand selection. Synthetic peptide libraries which include all sequences for a length
of a protein structure are one of these approaches. By means of these libraries, in vitro prediction
of the action of the library mixture as it passes through the surface where the protein of concern
is immobilized is possible. The ligands which possess affinity to the immobilized protein are
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suggested as ligands for the affinity chromatography application. It is also of choice to use
phage libraries and a screening method known as biopanning. Phage display method allows
determining suitable ligands not only for peptides and proteins but also for nonpeptide
structures (Figure 8).
Figure 8. Selection of the phage from the phage-displayed combinatorial peptide library [9]
A collection of phage is incubated with the target and retained ligands are considered to be
candidates for ligand [9]. At the end of the cycle, the process is repeated in order to increase
the amount of the protein which has required binding features. The sequence of the protein is
provided from the viral DNA. Phage display libraries are indisputably useful especially for
epitope mapping, vaccine development, bioactive peptides and some non-peptide structures
and the ligands determined using this method are appropriate for chromatographic analyses,
nevertheless there are some cases that limit the use of this technique, such as some optimization
problems and some issues as working in large scale as well as the limitation of the application
since peptides does not work unless it is a part of the phage, not in free solution [2].
Although its use in ligand selection for large scale of affinity chromatography is not wide,
ribosome display and systematic evolution of ligands by exponential enrichment (SELEX) may
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be mentioned as another approach and a potential ligand design and selection method due to
its versatility and rapidity [9]. Ribosome display method enables to select and develop a
protein library in vitro [2]. The principle of ribosome display is depicted in Figure 9. A collection
of DNA encoding the selected peptide is exposed to an in vitro transcription and translation
process, then in favourable condition, the complex of mRNA, peptide and ribosome since the
stop codon does not exist. Thereafter the complex is passed thtough the immobilised target
and the peptides which possess high affinity to the target are retained. At the end of this
process, it is possible to seperate mRNA usually by EDTA, then by means of reverse tran‐
scription, DNA are attained and amplified [9].
SELEX is a widely used technique for screening of aptamers which are nucleic acid ligands.
According to this method, a pool of DNA with a random sequence region attached to a constant
chain is constituted by amplification then transcribed to RNA. RNA pool is separated accord‐
ing to the affinity of RNA molecules to a target protein. DNA molecules obtained by reverse
transcription from retarded RNA molecules are amplified and the cycle is repeated.
The selection of the ligand may be designed according to the structure of the target protein as
well. Under the favor of combination of the structure-based design and combinatorial
chemistry, the efforts to synthesis a convenient structure are minimized [9].
Figure 9. Ribosome display method [9]
1.3. Immobilization
The immobilized ligand is an essential factor that determines the success of an affinity
chromatographic method [12]. The method which is used for affinity ligand immobilization is
important because actual or apparent activity of the final column can be affected. Decrease in
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ligand activity which result in multisite attachment, inappropriate orientation or steric
hindrance can be observed if the correct procedure is not pursued [21]. Several methods are
available to couple a ligand to a pre-activated matrix. The correct selection of coupling method
depends on the ligand characteristics [4].
Before ligands are coupled matrix is activated. Among several methods used for activation,
the cyanogen bromide activation is the most frequently preferred. Activation using this
method produces a highly reactive cyanate ester [7]. The ligands are attached to the support
via primary aromatic or aliphatic amino groups. High toxicity of cyanogen bromide is the
disadvantage of this method [13,19]. Subsequent coupling of ligands to the activated matrix
results in an isourea linkage. Despite the popularity of this method, the isourea linkage of the
ligands causes several problems during the purification procedure, including nonspecific
binding due to charge and leakage of the ligand because of instability of the isourea bond. N-
hydroxysuccinimide (NHS) esters have also been used for immobilizing ligands. The prepa‐
ration of active esters requires a matrix that contains carboxylic groups. Such matrices can be
easily obtained from agarose by activation of the hydroxyl groups with different reagents,
including cyanogen bromide, activated carbonates, etc. and successive reaction with ω-amino
acids of different sizes depending on the length of the spacer arm required. The NHS ester is
then prepared by mixing the carboxylic matrix with dicyclohexylcarbodiimide and NHS. Due
to the stability problem a different method based on N,N,N′,N′-Tetramethyl (succinimido)
uronium tetrafluoroborate can be also used. The covalent attachment of ligands to such
activated carriers provides the production of stable amide bonds. Another method for
activating polysaccharides is the use of N′N-disuccinimidyl carbonate (DSC), which forms
highly reactive carbonate derivatives with polymers containing hydroxyl groups. These
derivatives react with nucleophiles under mild, physiological conditions (pH 7.4), and the
procedure results in a stable carbamate linkage of the ligand coupled to the carrier. The
immobilization of different ligands (e.g., enzymes, enzyme inhibitors, antigens and antibodies)
on activated carbonate carriers has been achieved, together with excellent maintenance of
biological activity of the proteins [7]. Pre-activated commercial matrices are also available
(Table 2) to avoid many steps and problems of chemical activation process. A wide range of
coupling chemistries, involving primary amines, sulfhydryls, aldehydes, hydroxyls and
carboxylic acids are available for covalently attaching ligands to the matrices [12]. The use of
commercially available, pre-activated media is recommended to save time and avoid the use
of the potentially hazardous reagents that are required in some cases [4].
After the activation of the support material, it is ready for the immobilization process of the
ligand. In case the ligand is a small molecule, steric hindrance will occur between the immo‐
bilized support and the compound of interest (Figure 10). This may reduce or totally block
specific binding of the substance. Use of the supports having a spacer arm attached or
attachment of a spacer molecule to the support before immobilization of the ligand generally
solves this problem. Spacer arm keeps ligand at a suitable distance from the surface of the
support (Figure 9), thus the substance of interest will not be prevented to attach to the
immobilized ligand. It is possible to bind spacer arms directly to the support prior to the
imobilization of the ligand. Then a secondary reaction provides the attachment of ligand to
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the spacer. The substance of interest doesn’t be able to bind the ligand unless the spacer arm
is long enough, but it is also possible to shorten the spacer arm in salt buffer [19].
 
 
                                                   
Spacer 
arm ligand 
ligand 
Figure 10. Spacer arm, keeping ligand at a suitable distance from the surface of the support
Properties of an ideal spacer arm are listed below:
1. It should be long enough (at least 3 atoms) to keep the substance at an appropriate distance.
2. It should be inactive not to cause a non-specific binding.
3. It should have bifunctional group for the reaction with both support and the sample [9].
Compounds which have diamine groups such as hexanediamine, propanediamine and
ethylenediamine are the most preferred spacer arms used in affinity cromatography. Some
other examples of spacer arms are shown in Table 3 [19].
The following step is the immobilization of ligands on the activated matrix by isourea bonds.
Immobilization through isourea linkage has some disadvantages including nonspesific
binding of the ligand because of the instability of the bonds. Another method for immobiliza‐
tion is to use active esters such as N-hydroxy-succimide (NHS) esters. The carboxyl groups
required for preparation of active esters can be prepared by activation of hydroxyl groups of
Product name Functional group specifity
UltraLink lodoacetyl resin -SH
CarboLink Coupling resin -CHO, C=O
ProfinityTM Epoxide resin -NH2, -OH, -SH
Affi-Gel 10 and 15 -NH2
Pierce CDI-activated resin -NH2
Epoxy-activated SepharoseTM 6B -NH2, -OH, -SH
CNBr-activated Sepharose 4 Fast Flow -NH2
EAH SepharoseTM 4B -COOH, -CHO
Thiopropyl SepharoseTM 6B -SH
Tresyl chloride-activated agarose -NH2, -SH
Table 2. Activated commercially available resins of affinity chromatography
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agarose. The ligands attach to this type of matrix via amide bonds. It is also possible to activate
polysacharides by formation of highly reactive carbonate derivatives. In this case the polymer
which contains hydroxyl groups is activated by the use of N’N-disuccinimidyl carbonate
(DSC). The resultant carbonate derivatives create stable carbamate bonds with nucleophiles
under mild, physiological conditions. Immobilization methods can be categorized as follow
(Figure 11) [7].
 
General types of immobilization methods 
Covalent methods  Noncovalent methods  Coordination methods 
Biospecific adsorption Entrapment Non‐specific adsorption 
Figure 11. Immobilization methods used in affinity chromatography
Name Structure
Alkylamine
O C
NH
NH R NH2
Diamine H2N R NH2
Polypeptides
O C
NH
NH CH
R
C NH
O
CH
R
COOH
Polyamine
O C
NH
NH (CH2)2 NH (CH2)2 NH2
Polyether -0(CH2)2O(CH2)2O(CH2)2OH
Amino acid NH2RCOOH
Table 3. Some examples for spacer arms and their structures
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1.3.1. Noncovalent immobilization technique
The simple adsorption of ligand to surface, binding to a secondary ligand, or ligand immobi‐
lization through a coordination complex can be classified as this type of immobilization. This
technique can be subdivided as follow;
a. Nonspecific Adsorption; It is based on the attachment of ligand to support that has not
been specifically functionalized for covalent attachment. Adsorption of the ligand to a
support depends on the chemical characteristics of both the ligand and support. Columbic
interactions, hydrogen bonding, and hydrophobic interactions involve in this type of
immobilization.
b. Biospecific Adsorption; In this type of noncovalent immobilization method the ligand of
interest bind to a secondary ligand attached to the support. Although a variety of
secondary ligands can be used for this purpose, two of the most common are avidin and
streptavidin for the adsorption of biotin-containing compounds and protein A or protein
G for the adsorption of antibodies.
c. Coordination Complexes; A coordination complex can be used to prepare an immobilized
ligand in some cases. This is used to place metal ions into columns for immobilized metal-
ion affinity chromatography (IMAC) which is based on the formation of a complex
between a metal ion and electron donor groups.
1.3.2. Covalent immobilization methods
Covalent immobilization is the most popular method in affinity chromatography. In this
method, it is necessary to activate the ligand and/or the support first. Activation of the ligand
can be conducted when it is desired to couple this ligand through a specific region. An example
is the creation of aldehydes in the carbohydrate regions of an antibody for its attachment to a
support that contains amines or hydrazide groups. The use of an activated support is more
common for ligand immobilization but tends to be less specific in nature. Examples include
the immobilization of proteins through their amine groups to supports activated with N-
hydroxysuccinimide or carbonyldiimidazole. The support used for covalent immobilization
must meet several requirements. First, sufficient number of groups for activation and ligand
attachment should be. Hydroxyl groups on the support are employed in most covalent
coupling methods. Depending on how its surface is activated, a support can be used to
immobilize ligands through their amine, sulfhydryl, hydroxyl, or carbonyl groups, among
others.
1. Amine-Reactive Methods; Amine groups is often used for the immobilization of proteins
and peptides. Specific methods are cyanogen bromide method, reductive amination, N-
hydroxysuccinimide technique, and carbonyldiimidazole method.
a. Cyanogen Bromide Method ; The cyanogen bromide (CNBr) method was the first
technique used on a large scale for immobilizing amine-containing ligands and involves
the derivatization of hydroxyl groups on the surface of a support to form an active cyanate
ester or an imidocarbonate group. Both of these active groups can couple ligands through
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primary amines, but the cyanate ester is more reactive than the imidocarbonate. The CNBr
method utilizes relatively mild conditions for ligand attachment, making it suitable for
many sensitive biomolecules. But one problem with this approach is that the isourea
linkages obtained by the reaction of CNBr with the support are positively charged at a
neutral pH. This means that these groups can act as anion exchangers and nonspecific
binding can be occur. Other problems with this method include the toxicity of CNBr,
requiring the use of adequate safety precautions during the activation process, and the
leakage of ligands that can result from CNBr-activated supports (Figure 12).
OH
OH OH
OH
O-C=N
O-C-NH-Ligand
+NH
O
O
C = NH
O
O
C = NH-Ligand
Ligand-NH2
Ligand-NH2
Hydroxyl-containing 
matrix Cyanate ester
Imidocarbonate
pH 7.5 - 8.5
CNBr
pH 11 pH 7.5 - 8.5
Figure 12. Cyanogen bromide immobilization method patway [8]
b. Reductive amination (also known as the Schiff base method); Reductive amination
couples ligands with amine groups to activated periodate is used to oxidize diol groups
on the support’s surface to give aldehydes. This can be performed directly on carbohy‐
drate-based supports like dextran or cellulose. However, materials like silica or glass must
first be treated to place diols on their surface. This can be accomplished by reacting the
silica or glass with γ-glycidoxypropyltrimethoxysilane, followed by acid hydrolysis.
When an amine-containing ligand reacts with the aldehyde groups, the resulting product
is known as a Schiff base. Since this is a reversible reaction, the Schiff base must be
converted into a more stable form. This is achieved by including sodium cyanoborohy‐
dride in the reaction mixture. Cyanoborohydride is a weak reducing agent that converts
the Schiff base into a secondary amine without affecting the aldehydes on the support.
After the coupling reaction is completed, the remaining aldehyde groups can be removed
by treating the support for a short period of time with a stronger reducing agent (i.e.,
sodium borohydride) or by reacting these groups with an excess of a small amine-
containing agent (e.g., ethanolamine). The Schiff base method is relatively easy to perform
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and often gives a higher ligand activity than other amine-based coupling methods. This
also results in ligands that have stable linkages to the support and that can be used for
long periods of time. However, there are some disadvantages of this method. One is the
need to work with relatively hazardous agents such as sodium cyanoborohydride and
sodium borohydride. Thus, care must be taken to perform this technique with proper
ventilation and safety precautions. The use of sodium borohydride for the removal of
excess aldehyde groups must also be carried out with caution, since the use of conditions
that are too harsh may result in the loss of ligand activity.
c. N-Hydroxysuccinimide Method; The N-hydroxysuccinimide (NHS) method is another
technique often employed when immobilizing biomolecules through amine groups. This
gives rise to the formation of a stable amide bond. There are a number of ways a support
can be activated with NHS. The relative ease with which activated supports can be
prepared is one advantage of the NHS method. But the fast hydrolysis of NHS esters tends
to compete with the immobilization of ligands. This rate of hydrolysis increases with pH
and is particularly important when dealing with dilute protein solutions. The half-life of
these NHS groups at pH 7 and 0°C is approximately 4 to 5 h and decreases to as little as
10 min at pH 8.6 and 4°C (Figure 13).
d. Carbonyldiimidazole Method; Carbonyldiimidazole (CDI) can also be used to activate
supports for the immobilization of amine-containing ligands. This reagent can react with
materials that contain hydroxyl groups to produce an acylimidazole, which forms an
amide linkage as the result of the interaction with primary amines on a ligand. Supports
with hydroxyl groups will react with CDI to produce an imidazolylcarbamate. The
reaction of imidazolylcarbamata with primary amines proceeds at pH 8.5 to 10.0. The CDI
method is relatively simple and easy to perform. In addition, supports that have been
activated by production imidazolylcarbamate groups are more stable to hydrolysis than
those activated by the NHS method. A CDI-activated support is stable when stored in dry
dioxane, with a half-life of greater than 14 weeks. Another advantage of this method is
that the amide linkages formed by this technique (as well as those created by the NHS
method) are more stable than the isourea linkages obtained by CNBr immobilization. One
disadvantage of the CDI method is that it tends to produce ligands with a lower activity
than alternative techniques (e.g., reductive amination) (Figure 14).
e. Other methods; One example is the use of cyanuric chloride (or 2,4,6-trichlorotriazine) to
activate hydroxyl- or amine-containing supports for ligand attachment. Cyanuric chloride
has been widely employed as a cross-linking agent and as a reagent for protein
modification. It has three reactive acyl-like chlorines, each of which has a different
chemical reactivity. The first chlorine is reactive toward hydroxyls and amines at 4°C and
pH 9. After the first chlorine reacts, the second requires a slightly higher temperature for
its reaction (20°C), and the third chlorine needs an even higher temperature (80°C). Other
techniques for amine-containing ligands include the azalactone, divinylsulfone, bisoxy‐
lane, ethyldimethylaminopropyl carbodiimide, and tresyl chloride-tosyl chloride meth‐
ods. Some of these methods are specific for certain supports (e.g., the azalactone method),
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while others can be used with a variety of materials. The final selection among these
approaches will often depend on the type of ligand being immobilized, the support
desired for this ligand, and the conditions that can be tolerated by both the ligand and
support during the immobilization process.
2. Sulfhydryl-Reactive Methods; The use of sulfhydryl groups on ligands is another
approach for preparing affinity supports. If a ligand has a free sulfhydryl group on its
surface, using this group is advantageous, since it often provides site-specific immobili‐
zation and a cleavable product. If the ligand is a protein or peptide that has no free
sulfhydryl groups but that does have a disulfide bond, this bond can be reduced to allow
ligand attachment. It is also possible to introduce sulfhydryl groups on a ligand by
thiolating aminesor carboxyl groups. A support can be activated in several ways for the
immobilization of ligands through sulfhydryl groups. Unlike amine-reactive methods,
amine-containing 
matrix
NH2 + N O C (CH2)n C O N
O
NH
OO
O O
O
C (CH2)n C O N
O
OO
O
NHS activated support
Ligand - NH2pH 7-8
NH C (CH2)n C O
OO
NH - Ligand
DMF
Figure 13. N-Hydroxysuccinimide immobilization method [8]
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where hydroxyl groups on the support are generally used, most sulfhydryl-reactive
methods require the introduction of an amine,carboxyl group, or some other intermediate
site onto the support. For example, silica cannot be used directly with sulfhydryl-reactive
methods but must be reacted with aminopropyltriethoxysilane or mercaptopropyltrime‐
thoxysilane to convert it into a suitable form.There are various approaches that can be
used to immobilize ligands with sulfhydryl groups. The following subsections examine
some of these techniques, including the haloacetyl, maleimide, and pyridyl disulfide
methods.
a. Haloacetyl Method; The haloacetyl method uses supports that contain iodoacetyl or
bromoacetyl groups for the immobilization of ligands through sulfhydryl residues. These
supports are usually prepared via the reaction of an amine-containing material with
iodoacetic or bromoacetic acid in the presence of ethyldimethylaminopropyl carbodii‐
mide (EDC) at pH 4 to 5. EDC reacts with the carboxylic acid in iodo- or bromoacetic acid
carboxyl-containing 
matrix
COOH +
C O
O
carbamate support
Ligand - NH2pH 9-10
NH - Ligand
Carbonyldiimidazole
N N N NC
O
N NC
O
C
O
Figure 14. The carbonyldiimidazole immobilization method [8]
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to form a reactive ester, which can react with primary amine groups on the support. The
second part of this process involves combination of the haloacetyl-activated support with
a ligand containing a sulfhydryl group. This reaction proceeds by nucleophilic substitu‐
tion and produces a thioether. The resulting bond is comparable to an amide linkage in
stability. Although the reactivity of haloacetyl-activated supports toward sulfhydryls is
relatively selective, these can react with methionine, histidine, or tyrosine under appro‐
priate conditions. If the immobilization is carried out above pH 8, amines can also react
with these supports.
b. Maleimide Method; Maleimides are another group of reagents employed for the selective
coupling of a ligand through sulfhydryl groups. These tend to be more selective than a
haloacetyl for such a reaction. The activation of a support with a maleimide is accom‐
plished by using a homobifunctional or heterobifunctional cross-linking agent. One agent
employed for this purpose is bis-maleimidohexane (BMH), which is a homobifunctional
cross-linker with a maleimide group on both ends. The first of these groups can react with
a support that has a sulfhydryl group. After the excess BMH has been washed away, the
maleimide at the other end can react with a sulfhydryl group on a ligand.
c. Pyridyl Disulfide Method ; Pyridyl disulfide (or 2,2′-dipyridyldisulfide) is a homobifunc‐
tional cross-linking agent used for immobilizing ligands with sulfhydryl groups to
supports that contain sulfhydryls on their surface. Activation of the support is accom‐
plished by disulfide exchange between the sulfhydryl groups on the support and pyridyl
disulfide, giving rise to the release of pyridyl-2-thione.
d. Other Methods; Divinylsulfone (DVS) can be used to activate a hydroxylcontaining
support by introducing a reactive vinylsulfonyl group on its surface at pH 10 to11. This
support can then be reacted with ligands that contain sulfhydryl, amine, or hydroxyl
groups, with the rate of this reaction following the order –SH > –NH > –OH. Although the
resulting bond for a sulfhydryl group is labile, the linkage for amine-containing ligands
is more stable.
3. Hydroxyl-Reactive Methods; A number of methods have been used to couple ligands
through hydroxyl groups. However, unlike many amine- and sulfhydryl-reactive
methods, techniques for hydroxyl-containing ligands are not that selective. For example,
the divinylsulfone method can be used for coupling an amine-, sulfhydryl-, or hydroxyl-
containing ligand. Many supports used in affinity chromatography already contain
hydroxyl groups on their surface. One way for the activation of these groups is to
introduce bisoxirane (epoxy) groups. The most frequently used oxirane for this purpose
is 1,4-butanediol diglycidyl ether, which contains two epoxy groups. One of the epoxy
groups can react with the hydroxyl groups on a support while the other is used for
coupling ligands containing sulfhydryl, amine, the reactivity of the terminal epoxide to
other groups follows the order –SH > –NH > –OH. Strong alkaline conditions (pH 11) allow
coupling by this method through hydroxyl groups, while amines and sulfhydryl groups
can react at a lower pH (pH 7 to 8). Cyanuric chloride is another agent used for attaching
a hydroxyl-containing ligand to a support. In this method, this can only be used effectively
in the absence of amine groups due to the higher reactivity of these groups. As before‐
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mentioned, divinylsulfone can be used for coupling hydroxyl-containing ligands. This,
however, is not usually performed if the immobilized ligand is present at a pH higher
than 9 to 10.
4. Carbonyl-Reactive Methods; Although most immobilization techniques involve coupling
ligands through amine or sulfhydryl groups, the large number of such groups can create
a problem with improper orientation or multipoint attachment. This can be avoided by
using alternative groups that occur only in specific locations on the ligand. One example
is the immobilization of antibodies through their carbohydrate residues. To use the
carbohydrate groups of an antibody (or any other glycoprotein) for immobilization, these
groups must first be oxidized to form reactive aldehyde groups. This can be accomplished
by enzymatic treatment; however, it is usually performed through mild treatment with
periodate. These aldehyde groups are then reacted with a support containing amine or
hydrazide groups for ligand immobilization. This approach has been used not only for
antibodies but also for glycoenzymes, RNA, and sugars. Supports with amine groups can
be used for coupling aldehyde-containing ligands by reductive amination. Hydrazide-
activated supports can also be employed for immobilizing ligands with aldehyde groups.
Such supports can be prepared by formation aldehyde groups on the support and reaction
of these with an excess of a dihydrazide (e.g., oxalic or adipic dihydrazide). An advantage
of using a hydrazide-activated support is that no reducing agent is needed to stabilize the
linkage between the ligand and support, as is required in reductive amination.
5. Carboxyl-Reactive Methods; There are currently no activated supports that react
specifically with a ligand containing carboxyl groups. This is a result of the low nucleo‐
philicity of carboxyl groups in an aqueous solution. However, there are reagents that will
react with carboxylic acids and allow them to be activated for ligand attachment. 1-
Ethyl-3-(dimethylaminopropyl) carbodiimide is an example of such a reagent. One
problem of this process is that severe cross-linking is possible, since amine groups as well
as carboxyl groups can react if excess EDC is present. In addition, the activated derivative
formed, O-acylisourea, is not stable in an aqueous environment. This means that the
activated ligand must be used immediately for immobilization without further pu‐
rification.
6. Other Immobilization Techniques; Along with noncovalent and covalent immobilization
methods, other techniques have been developed for the preperation of affinity supports.
Such methods include entrapment, molecular imprinting, and the use of the ligands as
both the support and stationary phase. Although these methods are not as common as the
approaches already examined, they have important advantages in some applications [8].
Activation methods which are used in affinity chromatography can be summarized as follow:
Amine groups :
• Cyanogen bromide (CNBr) method
• Schiff base (reductive amination) method
• N-hydroxysuccinimide (NHS) method
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• Carbonyldiimidazole (CDI) method
• Cyanuric chloride method
• Azalactone method (for Emphaze supports)
• Divinylsulfone (DVS)
• Epoxy (bisoxirane) method
• Ethyl dimethylaminopropyl carbodiimide (EDC)
• method
• Tresyl chloride/tosyl chloride method
Sulfhydryl groups:
• Azalactone method (for Emphaze supports)
• Divinylsulfone method
• Epoxy (bisoxirane) method
• Iodoacetyl/bromoacetyl method
• Maleimide method
• Pyridyl disulfide method
• TNB-thiol method
• Tresyl chloride/tosyl chloride method
Hydroxyl groups:
• Cyanuric chloride method
• Divinylsulfone method
• Epoxy (bisoxirane) method
Aldehyde groups
• Hydrazide method
Carboxyl groups
1.4. Elution
Elution is one of the critical step for successful separation. Sample application in affinity
chromatography is performed usually by injection or application in the presence of mobile
phase which is prepared in appropriate pH, ionic strength and solvent composition for solute-
ligand binding. This solvent is referred as application buffer [8]. In the presence of application
buffer, compounds which are complementary to the affinity ligand will bind while the other
solutes in the sample will tend to pass through the column as nonretained compounds. After
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all nonretained components are washed off the column, the retained solute or together with
ligand as solute-ligand complex can be eluted by applying a solvent. This solvent which is
referred as elution buffer represents the strong mobile phase for the column. Later all the
interest solutes are eluted from the column, regeneration is performed by elution with
application buffer and the column is allowed to regenerate prior to the next sample application
[4,8,21]. Step gradient elution or in other word on/off elution method is the most common
method employed for affinity chromatography. Figure 15 shows the typical separation in
affinity using step gradient elution.
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Figure 15. Typical separation in affinity using step gradient elution.
Step elution mode is employed if the ligans have high affinity for the target molecule. It is also
possible to use isocratic elution in affinity chromatography. This elution mode generally
selected if the target molecule and ligand have weak interaction. This approach is known as
Weak Affinity Chromatography or Dynamic Affinity Chromatography [8,21].
In affinity chromatography there are many factors such as strength of solute-ligand interaction,
the amount of immobilized ligand present and the kinetics of solute-ligand association and
dissociation which have important influences on retention and elution of the compound. The
reaction between the target protein (T) and ligand (L) on the other word binding (adsorption)
and elution (desorption) process can be explain by following equation in case of a target protein
has single site binding to a ligand [1,4,21].
KD is the equilibrium dissociation constant
[L] is the concentration of free ligand
[T] is the concentration of free target 
Binding
Elution
[L][T]
[LT]
KD =
L  +  T  LT 
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[LT] is the concentration of the ligand/target complex
The equation that is placed below explains the bound target-total target ratio. In order to
achieve successful binding the ratio should be near 1 in this equation.
Bound target
Total target ≈
L 0
KD+L0
L0 is the concentration of ligand (usually 10-4 - 10-2M)
KD is the equilibrium dissociation constant
KD can be changed by pH, ionic strength, temperature and other parameters. Therefore these
parameters can be used to control the binding and elution efficiency of the reaction [1,4,22]
Obtaining stable biomolecules in high yield and purity is aimed for elution process. Elution is
achieved by reducing the association constant of the ligand-solute interaction. Biospecific or
non-specific elution can be utilized. Biospecific elution is based on solute displacement from
the column by addition of molecule that acts as a competing agent. Two different types of
biospecific elution can be applied for elution. In first method, normal role elution, molecule
competes with the ligand for binding the desired solute. In second type of biospecific elution,
reversed role elution, molecule competes with desired solute for binding the ligand [13]. The
main advantage of biospecific elution is that a target can be gently removed from the column.
However this elution is slow and generally results in broad solute peaks. Additionally
competing agent needs to be removed from the eluted solvent therefore usage is limited.
Another disadvantage especially in analytical application is need to use a competing agent
that does not produce a large background signal under the conditions used for analyte
detection [8]. Non-specific elution is performed by changing solvent conditions like pH, ionic
strength and polarity. High concentration of chaotropic salts (NaCl, MgCl2 or LiCl), denatu‐
rating agents and detergents (guanidine hydrochloride, sodium dodecyl sulfate and urea) can
be used. Organic solvents can be used especially for the elution of low molecular weight
compounds [13]. Alteration in structure of the solute or ligand which leads to a lower associ‐
ation constant and lower solute retention is provided by nonspecific elution [8]. Non-specific
elution is faster than specific elution but there is a risk for denaturation of solute. The conditions
which are applied for the elution may be too hard for column. If this is not considered it may
result in long column regeneration times or irreversible loss of ligand activity [8].
For biospecific elution solvent is selected according to the type of target and ligand. The solvent
usually has a pH and ionic composition similar to the application buffer but contains a
competing agent. Reversed role elution is generally preferred when the target is a small
compound while the normal elution is often used for isolation of macromolecules. Readily
available in an inexpensive form and be soluble in the elution buffer are desired properties for
competing agent in reverse role elution. In reversed-role elution it must be possible to remove
the competing agent from the target when the affinity column is used for purification [8].
A wide range of mobile phase additives can be used in non-specific elution. In this elution
nature of the target-ligand interaction is changed. This can be achieved by several ways such
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as altering pH of the targets and ligands that interact by weakly acidic or basic groups.
Changing pH can lead to the alteration in the conformation of the target or ligand. Either
increasing or decreasing of pH value can be used for this purpose but decreasing of pH is
commonly preferred. Irreversibly denaturation of target, ligand or support may occur in this
step. Collection of the eluted target in a neutral pH buffer and regeneration the column as soon
as possible after the elution step can overcome this problem [8]. Changes in ionic strength
induced by high salt solutions are a second way for nonspecific elution. Disruption of ionic
bonds can be achieved by this method but hydrophobic interactions are promoted. Chaotropic
salts (NaCl, MgCl2 or LiCl) are useful for altering retention of targets. They distrupt the stability
of water and interfere with hydrophobic interactions [8,23]. The main advantage of using either
chaotropic salt of a change in ionic strength is that this usually leads to gentle elution of the
target in an active form [8]. Denaturating agents such as urea, guanidine hydrochloride and
sodium dodecyl sulfate which dissociate hydrogen bonds can also be used for elution. Sodium
dodecyl sulphate (SDS) contains both hydrophobic and strong ionogenic groups and binding
to hydrophobic regions results in a layering of negative charges on the protein’s surface,
causing irreversible unfolding of the structure. The denaturating effect of these solutions limits
their usage. They should be only used in analytical applications if the ligand is quite stable or
in preparative applications if both the ligand and target are relatively stable and it is enable to
recover their activity after such elution [8,23]. Organic solvents in the mobile phase are also
used in some cases such as using of 1-propanol in chiral affinity separations in order to improve
solute retention and produce narrow peaks for good resolution. Polyols like ethylene glycol
are also utilized in affinity separations [8]. In order to select the elution buffer several ap‐
proaches can be followed. However the best way is that the buffer should be selected based
on information in the literature, structure of the ligand, target and past experiences with these
substances [8].
2. Types of affinity chromatography
The type of ligand can be used to divide affinity techniques into various subcategories such
as lectin, immunoaffinity, dye ligand etc. These techniques are placed as below [1].
2.1. Immunoaffinity chromatography
Immunoaffinity chromatography is one of the most popular techniques of affinity derivatived
method and it enables to produce ligands in case the ligand required is not available [7]. In
this technique, stationary phase comprises of an antibody or antibody-related agent [1]. It is
possible to isolate variable subtances using this technique due to high specifity of antibodies
[1]. It is reported that immunoaffinity chromatography may be used for natural food contam‐
inants such as aflatoxins, fumonisins and ochratoxins [11].
On the purpose of purification using antibodies as ligands, antibodies initially are immobilized
on a support. In order to,bind the ligand on the surface of the support properly, protein A and
G are usually used as a bridge which provides enough space for the ligand-protein binding.
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Columns, dialysis membranes, capillaries or beads may be used in immunoaffinity application
which is a non-covalent, irreversible purification process based on highly specific interactions
between analyte and antibody [11].
Initially, the antibodies should be purified prior to prepare the immunoaffinity column.
Precipitation with ammonium sulfate, ion-exchange chromatography, gel filtration chraoma‐
tography or affinity chromatography may be employed with the aim of antibody purification.
Activated beads which are coated with bacterial proteins A or G may be used as the support
material. Some parameters may be changed for the elution of the sample solution for example
the ionic conditions of mobile phase may be changed or chaotropic buffers may be used [11].
Both small and large analytes can be determined using direct detection in IAC. Additionally
it is possible to use this technique either separately or in combination with other chromato‐
graphic techniques [1]. If this technique is performed as part of HPLC system the method can
be referred as high performance immunoaffinity chromatography.
Immunoaffinity chromatography is probably the most highly specific of all forms of bioaffinity
chromatography. However this technique has some disadvantages such as: this technique
relatively high cost, leakage of ligands may accur from the column and sometimes the
desorption procedure results in partial denaturation of the bound protein [24].
2.2. Protein A or protein G affinity chromatography
Protein A is produced by Staphylococcus aureus while protein G is of group G Streptococci. These
ligands are capable of binding to many types of immunoglobulins at around neutral pH and
they dissociate in a buffer with a lower pH [1]. Protein A binds to the immunoglobulin G (IgG)
obtained by human and other mammalian species with high specificity and affinity. In some
cases protein G may be used instead of protein A [24]. These two ligands differ in their ability
to bind to antibodies from different species and classes. Strong specifity and binding properties
to immunoglobulins of protein A and protein G serve them as good ligands for the seperation
of immunoglobulins. Protein A and protein G have use as secondary ligands for the adsorption
of antibosies onto the support material in immunoaffinity applications. This method may also
be employed in case high antibody activity or replacement of the antibodies in the affinity
chromatography is needed [1].
2.3. Lectin affinity chromatography
Lectins which are non-immun proteins are produced by plants, vertebrates and invertebrates.
Especially various plant seeds synthesize high levels of lectins [24]. Certain types of carbohy‐
drate residues may be seperated via this method due all lectins have the ability to recognize
and bind these types of compounds. Mostly used lectins for affinity columns are concanavalin
A, soybean lectin and wheat germ agglutinin [1, 24]. Concanavalin A is specific for α-D-
mannose and α-D-glucose residues while wheat germ agglutinin binds to D-N-acetyl-
glucosamine. Lectins which are commonly used for the isolation of compunds containing
carbohydrates such as polysaccharides, glycoproteins and glycolipids in affinity chromatog‐
raphy are given in Table 4. [1].
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Lectin Source Sugar specificity Eluting sugar
Con A Jack bean seeds α- D-mannose, α- D -glucose α - D -methyl mannose
WG A Wheat germ N-acetyl-β- D -glucosamine N-acetyl-β- D -glucosamine
PSA Peas α- D -mannose α- D -methyl mannose
LEL Tomato N-acetyl-β- D -glucosamine N-acetyl-β- D -glucosamine
STL Potato tubers N-acetyl-β- D -glucosamine N-acetyl-β- D -glucosamine
PHA Red kidney bean N-acetyl-β- D -glucosamine N-acetyl-β- D -glucosamine
ELB Elderberry bark Sialic acid or N-acetyl-β- D -glucosamine Lactose
GNL Snowdrop bulbs α -1→  3 mannose α -methyl mannose
AAA Freshwater eel α – L-fucose L -fucose
Table 4. Some lectins which are commonly used in affinity chromatography
Enzymes, inhibitors, cofactors, nucleic acids, hormones or cell chromatography can also be
utilized as ligands in bioaffinity chromatography types. Examples of these methods include
Receptor Affinity Chromatography and DNA Affinity Chromatography [21].
2.4. Dye-ligand affinity chromatography
Development of the dye-ligand affinity chromatography could be attributed to observation of
some proteins irregular elution characteristics during fractionation on gel filtration column in
presence of blue dextran. Blue dextran consists of a triazine dye (cibacron blue F3G-A)
covalently linked to high molecular mass dextran. Some proteins bind triazine dye and this
allows to its use as an affinity adsorbent by immobilization [24]. This method is especially
popular tool for enzyme and protein purification [21]. Dye-ligand adsorbents are of interest
due to inexpensiveness, ease of availablity and immobilization process. These adsorbents may
be used in analytical, preparative analysis and large scale studies. Although dye-ligand affinity
technique for pharmaceuticals may be preferred owing to these advantages, concerns about
leakage and toxicity has stopped its use. Therefore proteins purified using this technique is
convenient for analytical or technical uses. Procion Red HE3b, Red A, Cibacron Blue F3G-A
are some examples of dye-ligands which are used for purification [9].
2.5. Metal-chelate affinity chromatography (Immobilized-metal (Ion) affinity
chromatography)
In 1970s, first application of metal-chelate affinity chromatography which is later named as
"immobilized-metal (ion) affinity chromatography (IMAC) was perfomed. Metal-chelate
chromatography technique exploits selective interactions and affinity between transition metal
immobilized on a solid support (resin) via a metal chelator and amino acid residues which act
as electron donors in the protein of interest [25-26]. As well as aromatic and heterocyclic
compounds, proteins such as histidine, tyrosine, tyriptophane and phenylalanine posses
affinity to transition metals which form complexes with compounds rich in electrons [25,27].
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Among these amino acids histidine is the most commonly used one. Attachment of histidine
tags to the recombinant proteins polypeptides is the most known development in the field of
IMAC. Histidine and other metal affinity tags are widely used for protein purification [26].
Adsorbents may be prepared by binding chelators onto the surface and metals to the chelators.
Free coordination sites of the metal ions are needed for the analyte to bind to metal ions [25].
Zn2+, Ni2+ and Cu2+ are the most commonly used metal ions. Basic groups on protein surfaces
especially the side chain of hisitidine residues, are attracted to the metal ions to form a weak
coordinate bonds [24].
The metal ions in the class of hard Lewis acids such as K+, Ca2+, Mg2+, Fe3+; soft Lewis acids
such as Ag+, Cu+ and transition metals classified as borderline acids (Co2+, Cu2+, Ni2+) may be
used in IMAC applications, especially Ni2+ which has six coordination sites and electrochemical
stability. The affinity of the metals may be predicted according to the principles of soft acids
and bases which is the theory explaining one of the two atoms attached acts as a Lewis acid
and the other as a Lewis base. Ligands with oxygen (e.g. carboxylate), aliphatic nitrogen (e.g.
asparagin, glutamine) and phosphor (phosphorylated amino acids) are hard Lewis bases, as
the ones with sulfur (e.g. cysteine) are soft bases and those with aromatic nitrogen (e.g.
histidine, tryptophane) are borderline bases. In case Cu(II), Ni(II), Co(II) or Zn(II) ions are the
ions used in the IMAC, the target amino acids on the protein surface are imidazolyl, thiol and
indolyl groups; as carboxyl and phosphate groups are of that in case of the use of Fe(III) and
Mg(II). Histidine, tryptophane and cysteine are accepted to be the most important amino acids
for IMAC due to their strong affinity to metal ions and the retention times. It is reported that
histidine residues attached to the protein surface significantly change the retention time of the
protein of interest [26].
Chelating Compound Coordination Metal Ions
Aminohydroxamic acid bidentate Fe(III)
Salicylaldehyde bidentate Cu(III)
8-Hydroxy-quinoline (8-HQ) bidentate Al(III), Fe(III), Yb(III)
Iminodiacetic acid (IDA) tridentate Cu(II), Zn(II), Ni(II), Co(II)
Dipicolylamine (DPA) tridentate Zn(II), Ni(II)
ortho-phosphoserine (OPS) tridentate Fe(III), Al(III), Ca(II), Yb(III)
N-(2-pyridylmethyl)aminoacetate tridentate Cu(II)
2,6-Diaminomethylpyridine tridentate Cu(II)
Nitrilotriacetic acid (NTA) tetradentate Ni(II)
Carboxymethylated aspartic acid (CM-Asp) tetradentate Ca(II), Co(II)
N,N,N'-tri(carboxymethyl)ethylenediamine (TED) pentadentate Cu(II), Zn(II)
Table 5. Some examples of chelating compouns used in IMAC [28]
Affinity Chromatography and Importance in Drug Discovery
http://dx.doi.org/10.5772/55781
91
Multidentate chelating compounds are widely used in order to strengthen the complex which
is comprised of chelator, metal ion and protein. Different length of spacers is used to bind the
chelator onto the surface of the support. Type of the chelator influences the strength of the
chelation and retention power, for instance metal binds to the nitrogen atom and two carbox‐
ylate oxygens and reveals three free sites in case of tridentate iminodiacetic acid (IDA);
tetradentate nitrilotriacetic acid (NTA) binds the metal by an additional carboxylate oxygen
and this provides stronger chelation, but a weaker retention power. IDA is the chelator which
is commonly used in the applications of IMAC. Although most of the chelators are carboxy‐
methylated amines, there also some other compounds which are commonly used such as dye-
resistant yellow 2KT, OPS and 8-HQ [26]. Some examples of chelating compounds are given
in Table 5.
2.6. Boronate affinity chromatography
In case of use boronic acid or boronates as ligand of the affinity chromatography, this type of
methods are called boronate affinity chromatography. Most of the boronate derivatives are
known to bind compounds with cis-diol groups covalently at a pH above 8. Separation of
glycoproteins from non glucoprotein structures is possible by boronate affinity method due
to cis-diol groups of the sugars. For instance, this method may successfully performed to
seperate glucohemoglabin and normal hemoglobin or to determine different types of glyco‐
proteins in a sample [1].
There are many other chromatographic methods which are closely related to traditional
affinity chromatography. For example Analytical Affinity Chromatography (Quantitative
Affinity Chromatography or Biointeraction Chromatography) which is used as a tool for
determination of solute-ligand interactions [21]. It is possible to investigate several biological
systems, such as lectin/sugar, enzyme/inhibitor, protein/protein, DNA/protein interactions as
well as binding of drugs or hormones to serum proteins with this technique. Thus competition
of drugs with other drugs or endogenous compounds for protein binding sites may success‐
fully be detected by this method. Either immobilized drugs or immobilized proteins may be
used in the studies about drug-protein and hormone-protein binding, although protein-based
columns which may be use for multiple experiments are more common [1,29]. The competition
between two solutes for binding sites can also be examined by this method and this technique
is known as Frontal Affinity Chromatography [21]. Hydrophobic Interaction Chromatogra‐
phy and Thiophilic Adsorption methods also related to affinity chromatography. Immobi‐
lized thiol groups are used as ligands in Thiophilic Adsorption (Covalent/Chemisorption
Chromatography) in order to separation of sulfhydryl-containing peptides or proteins and
mercurated polynucleotides. In Hydrophobic Interaction Chromatography short non-polar
chain, such as those that were originally used as spacer arms on affinity supports provide
binding with proteins, peptides and nucleic acids. Chiral Liquid Chromatography methods
can be also considered as affinity based techniques [21]. These techniques are widely utilized
in pharmaceutical industry and clinical chemistry for the separation of individual chiral forms
of the drugs and the quantification of different chiral forms of drugs or their metabolites. Since
most of the ligands used in affinity chromatography are chiral, they may be preffered as
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stationary phases for chiral seperations. Protein-based and carbohydrate-based ligands may
be used as the stationary phases in the analysis of chiral compounds via HPLC [1]. Orosomu‐
coid (α1-acid glycoprotein), bovine serum albumine and ovomucoid (a glucoprotein of eggwhites) are some examples of protein-based stationary phases, while cyclodextrins (especially
β-cyclodextrin) are of carbohydrate-based stationary phases [1,29].
3. Affinity chromatography and drug discovery
There are a number of areas related to affinity chromatography that have also been of great
interest in pharmaceutical and biomedical analysis. One such area is the use of affinity
chromatography in drug discovery [12]. In drug discovery explaining the mechanism of action
of bioactive compounds, which are used as pharmaceutical drugs and biologically active
natural products, in the cells and the living body is important. For this pupose isolation and
identification of target protein(s) for the bioactive compound are essential in understanding
its function fully. Affinity chromatography is a useful method capable of isolating and
identifying target molecules for a specific ligand, utilizing affinity between biomolecules such
as antigen–antibody reactions, DNA hybridization, and enzyme–substrate interactions. Since
the development of affinity chromatography in the early 1950s, various types of target proteins
for bioactive compounds have been isolated and identified. Selected samples of the target
proteins isolated by affinity chromatography are listed in Table 6. Since then, affinity chro‐
matography has been gaining renewed attention as a widely applicable technique for the
discovery the target proteins for bioactive compounds [30].
Bioactive compound Molecular structure Target protein
E-64
(cystein protease
inhibitor) N
N
N
O
ONH
H2N
H
H
OO
OH
H
Cathepsin B, H, L
Indomethacin
(antitumor drug)
O
O
Cl
OH
CH3O
Glyoxalase 1
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Bioactive compound Molecular structure Target protein
Methotrexate
(anticancer drug)
N
N
N
N
N
N
HO
HO
O
O O
NH2
NH2
Dihydrofolate reductase
Deoxycytidine kinase
Resvertatrol
(health benefits
including life span)
OH
OH
HO
Tif1 (yeast elF4A)
Spliceostatin A
(splicing inhibitor)
N
O O
O
AcO
O
H HO
OCH3
Splicing factor 3b
Thalidomide
(sedative, anticancer
drug)
N
N
O O
O
O
H
Cereblon
Wortmannin
(PI 3-kinase inhibitor) O
O
O O
O
O
H
CH3O
O
Polo-like kinase 1 Polo-
like kinase 3
Table 6. Selected examples of the target protein(s) isolated and identified through affinity chromatography [30]
4. Conclusion
Liquid chromatographic techniques have been widely used in pharmaceutical and clinical
laboratories. Reversed phase, ion exchange, size exclusion and normal phase chromatogra‐
Column Chromatography94
phy are commonly used types of these techniques. Affinity chromatography which provides
analysis  of  bioactive  molecules  based  on  their  biological  functions  or  individual  struc‐
tures has become increasingly important as another liquid chromatography technique [1,12].
Affinity chromatography is  based on the simple principle that  every biomolecule recog‐
nize another natural or artificial molecule such as enzyme and substrate or antibody and
antigen [2,7].  In fact  this technique is  one of the oldest forms of liquid chromatography
method [8].  The first  use  may be  considered as  the  isolation of  α-amylase  by using an
insoluble substrate, starch, in 1910 just three years after the discovery of chromatography
by Tsewett  [6,9].  The modern applications have started since 1960s with the creation of
beaded agarose supports and the use of cyanogens bromide immobilization method. Since
then,  affinity  chromatography has  been gaining attention as  a  widely applicable  techni‐
que for discovering the target proteins for bioactive compounds [3]. Up to the present time
many different types of target proteins for bioactive compounds have been isolated and
identified by affinity chromatography [21]. Today affinity chromatography is utilized as a
valuable technique for the separation, purification and analysis of compounds present in
complex samples and used in biochemistry, pharmaceutical science, clinical chemistry and
environmental sciences. Application of affinity chromatography has significant advantag‐
es.  The  important  one  is  that  affinity  chromatography  involves  many  types  of  interac‐
tions between ligand and target such as steric effects, hydrogen bonding, ionic interactions,
van  der  Waals  forces,  dipol-dipol  interactions  and  even  covalent  bonds  while  other
chromatographic techniques involve just one or a few of them. The combination of these
multiple  interactions  leads  to  separation  with  high  selectivity  and  retention  in  affinity
chromatography [8].  However there are also several  drawbacks in affinity chromatogra‐
phy system,  such as  non-specific  binding of  irrelevant  proteins  during affinity  purifica‐
tion and chemical modification of bioactive compounds of interest used as ligands. These
drawbacks  limit  its  extensive  application.  After  the  completion  of  the  Human  Genome
Project drug discovery research has focused on an approach that includes identification and
characterization of molecular and cellular functions of a wide variety of proteins encoded
by genomes. Thus, bioactive compounds become more important not only as therapeutic
agents to treat diseases and disorders but also as useful chemical tools to examine their
complex  biological  processes  in  vitro  and  in  vivo  [30].  Affinity  chromatography  which
allows  explaining  the  mechanism  of  action  of  bioactive  compounds  that  are  used  as
pharmaceutical drugs and biologically active natural products, therefore, has also signifi‐
cant importance in modern drug discovery [30].
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